The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Research Methods · Statistics

Second pass at: Multiplicity when you track fifteen variables

KF
k.fonsecaTL2 Moderator20 Oct 2024#1

Posting this under the heading it deserves: Second pass at: Multiplicity when you track fifteen variables Everything below is what sits behind that.

I have seen SCALE (N Engl J Med, 2015) cited in support of a claim I do not think it supports, twice this month, so I would like to work through what it actually shows.

My reading is that the trial is sound for its own question and is being stretched to answer a different one. I might be wrong about that, which is why this is a topic rather than a correction.

What I would like from this discussion: someone who disagrees with me to say why, with the section of the paper they are relying on.

60 likes 21mo
FF
f.fontaineTL2 Moderator20 Dec 2024#2

Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p<0.05) might be too small to matter. A large effect might not be significant if sample size is small.

0 likes 19mo
RM
r.marsdenTL3Regular2 Feb 2025#3
f.fontaine, post #2: Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p Go to post

This follows post #2 rather than contradicting it.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

6 likes in reply to #2 18mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Regression to the mean in progress reports
On the subject in the title: Regression to the mean in progress reports Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the discussion…
HAAMTFAVDM+30 34 49k 12mo
[2026 update] Correlation in a self-tracked dataset: what it can support
Posting this under the heading it deserves: Correlation in a self-tracked dataset: what it can support Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA , 2024) cited in support of a…
GTARLS 2 31k 6h
What a confidence interval means, from scratch
What a confidence interval means, from scratch — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen STEP 8 ( JAMA , 2022) cited in support of a claim I do not…
MHSNO 2 2.6k 2mo
Multiplicity when you track fifteen variables
Multiplicity when you track fifteen variables — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-OSA ( N Engl J Med , 2024) and finding…
JATNNA 2 60k 11mo
Measurement error in home scales, with a worked standard deviation — the long version
On the subject in the title: Measurement error in home scales, with a worked standard deviation — the long version Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022).…
SKRRAWDYJD+96 105 2k 2mo

Related topics — sharing the tags number needed to treat, confounding, effect size

TopicParticipantsRepliesViewsActivity
Fixed versus detachable needles: the trade-offs
Posting this under the heading it deserves: Fixed versus detachable needles: the trade-offs Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I am…
HNAVPWSMRD+117 121 7.3k 18mo
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
ESKHVKASNP+99 110 61k 2d
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold?
The question in the title: Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen SURMOUNT-2 ( Lancet ,…
RONSPPSDOB+60 66 12k 16mo
Titles that describe the question, not the situation — what changed since
Posting this under the heading it deserves: Titles that describe the question, not the situation — what changed since Everything below is what sits behind that. Question in the title. Context below, and I…
ACAWCTDCR+29 33 29k 10mo
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
CSRHGBWTMR+41 45 808 2mo